GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
E4f1 | rn6_v1_chr10_-_13826945_13826945 | -0.13 | 2.4e-02 | Click! |
Atf7 | rn6_v1_chr7_-_144223429_144223429 | -0.07 | 2.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_65424802 Show fit | 56.11 |
ENSRNOT00000018468
|
Tnf receptor associated factor 4 |
|
chr2_+_189629297 Show fit | 55.29 |
ENSRNOT00000049810
|
DENN domain containing 4B |
|
chr4_+_70572942 Show fit | 45.39 |
ENSRNOT00000051964
|
|
|
chr4_-_57625147 Show fit | 39.21 |
ENSRNOT00000074649
ENSRNOT00000078961 |
ubiquitin-conjugating enzyme E2H |
|
chr17_+_43617247 Show fit | 37.15 |
ENSRNOT00000075065
|
histone cluster 1, H2ao |
|
chr18_-_77322690 Show fit | 33.81 |
ENSRNOT00000058382
|
nuclear factor of activated T-cells 1 |
|
chr12_+_37984790 Show fit | 33.34 |
ENSRNOT00000001445
|
VPS37B, ESCRT-I subunit |
|
chr10_+_11724032 Show fit | 31.18 |
ENSRNOT00000008966
|
TNF receptor-associated protein 1 |
|
chr17_-_43821536 Show fit | 29.89 |
ENSRNOT00000072286
|
histone H4 variant H4-v.1 |
|
chr13_-_50916982 Show fit | 25.37 |
ENSRNOT00000004408
|
BTG anti-proliferation factor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 67.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
5.1 | 56.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
7.9 | 55.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
7.7 | 46.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.4 | 37.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
8.7 | 34.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
8.5 | 33.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
11.1 | 33.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
10.4 | 31.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 30.3 | GO:0006412 | translation(GO:0006412) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 67.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 59.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 53.4 | GO:0005739 | mitochondrion(GO:0005739) |
15.4 | 46.1 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.2 | 46.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.6 | 43.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 35.3 | GO:0005654 | nucleoplasm(GO:0005654) |
3.7 | 33.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.2 | 33.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 32.5 | GO:0005794 | Golgi apparatus(GO:0005794) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 96.6 | GO:0003723 | RNA binding(GO:0003723) |
0.4 | 78.5 | GO:0042393 | histone binding(GO:0042393) |
1.6 | 71.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
3.2 | 66.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 49.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 48.3 | GO:0045296 | cadherin binding(GO:0045296) |
1.5 | 46.1 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 41.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 41.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.1 | 37.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 72.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.2 | 68.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 47.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.7 | 46.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.1 | 42.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.3 | 32.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 31.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.6 | 31.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 26.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.8 | 25.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 59.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 48.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
2.9 | 46.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.7 | 33.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 26.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.1 | 25.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 21.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 20.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 19.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.8 | 19.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |